Abraxis Bioscience, Inc.

Durham, North Carolina 27703

0 studies enrolling now · 5 studies all time

What they study most

Angina Pectoris, Breast Cancer, Breast Neoplasms, Coronary Artery Disease, Melanoma, Metastases, Metastases, Neoplasm, Neoplasms

Studies at this site

• A Safety Study of ABI-007 for In-Stent Restenosis — Completed
• Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma — Completed
• A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies — Completed
• Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer — Completed
• Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer — Completed